Skip to main content
Premium Trial:

Request an Annual Quote

West Virginia s Protea Seeks Cancer Biomarkers for Novartis

NEW YORK, Jan. 8-The West Virginian firm Protea Biosciences has struck a deal with Novartis to identify novel protein biomarkers for cancer, the company said today.

 

Researchers at the company will apply its proprietary "ultrasensitive" mass spectrometry technique to analyze and identify proteins associated with cancer.

 

Protea, which says it is the first biotech company in the state, was founded to commercialize technology developed at West Virginia University and the university's Health Sciences Center.

 

Details of the agreement were not released.

 

For further information about the company, see its website.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.